CS logo
small CS logo
Nuovo Ospedale Civile S. Agostino-Estense; Clinica Neurologica - Dipartimento di Neuroscienze

Modena, Emilia-Romagna, Italy

About Nuovo Ospedale Civile S. Agostino-Estense; Clinica Neurologica - Dipartimento di Neuroscienze


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Nuovo Ospedale Civile S. Agostino-Estense; Clinica Neurologica - Dipartimento di Neuroscienze


During the past decade, Nuovo Ospedale Civile S. Agostino-Estense; Clinica Neurologica - Dipartimento di Neuroscienze conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Nuovo Ospedale Civile S. Agostino-Estense; Clinica Neurologica - Dipartimento di Neuroscienze" #1 collaborator was "University of Modena and Reggio Emilia" with 2 trials as a collaborator, "University of Padova" with 2 trials as a collaborator, "University of Turin, Italy" with 2 trials as a collaborator, "Azienda Ospedaliera Niguarda Cà Granda" with 1 trials as a collaborator and "Azienda Ospedaliero Universitaria Maggiore della Carita" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

Clinical Trials Conditions at Nuovo Ospedale Civile S. Agostino-Estense; Clinica Neurologica - Dipartimento di Neuroscienze


According to Clinical.Site data, the most researched conditions in "Nuovo Ospedale Civile S. Agostino-Estense; Clinica Neurologica - Dipartimento di Neuroscienze" are "Alzheimer Disease" (3 trials), "Alzheimer's Disease" (2 trials) and "Amyotrophic Lateral Sclerosis" (2 trials). Many other conditions were trialed in "Nuovo Ospedale Civile S. Agostino-Estense; Clinica Neurologica - Dipartimento di Neuroscienze" in a lesser frequency.

Clinical Trials Intervention Types at Nuovo Ospedale Civile S. Agostino-Estense; Clinica Neurologica - Dipartimento di Neuroscienze


Most popular intervention types in "Nuovo Ospedale Civile S. Agostino-Estense; Clinica Neurologica - Dipartimento di Neuroscienze" are "Drug" (7 trials). Other intervention types were less common.
The name of intervention was led by "Gantenerumab" (5 trials), "Placebo" (3 trials), "Placebo Oral Tablet" (2 trials), "Colchicine 1 MG Oral Tablet" (1 trials) and "Rapamycin" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Nuovo Ospedale Civile S. Agostino-Estense; Clinica Neurologica - Dipartimento di Neuroscienze


The vast majority of trials in "Nuovo Ospedale Civile S. Agostino-Estense; Clinica Neurologica - Dipartimento di Neuroscienze" are 7 trials for "All" genders.

Clinical Trials Status at Nuovo Ospedale Civile S. Agostino-Estense; Clinica Neurologica - Dipartimento di Neuroscienze


Currently, there are NaN active trials in "Nuovo Ospedale Civile S. Agostino-Estense; Clinica Neurologica - Dipartimento di Neuroscienze". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Nuovo Ospedale Civile S. Agostino-Estense; Clinica Neurologica - Dipartimento di Neuroscienze, undefined suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Nuovo Ospedale Civile S. Agostino-Estense; Clinica Neurologica - Dipartimento di Neuroscienze, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".